Much of the research till date involving TRAIL signaling has focused on its usage in cancer treatment; however, an increasing number of publications are starting to report on the predominance of TRAIL resistance in primary human tumor cells [10], which require sensitization for the induction of TRAIL-based apoptosis. This evidence concerns the gene TNFSF10 and cancer.